Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,781,379
+$1,975,697 QoQ
Shares Held
187,848
+68.0% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.21606831054895.ToString("F0")%
Shared 0.ToString("F0")%
None 5.7839316894510455.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. KALV ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,781,379 | 187,848 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,805,682 | 111,807 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,125,041 | 92,368 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,509,963 | 133,566 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $956,619 | 82,896 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $694,581 | 82,005 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $769,178 | 66,423 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $636,426 | 54,026 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $603,756 | 50,907 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $624,382 | 50,970 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $554,360 | 57,566 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $637,785 | 70,865 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $557,234 | 70,895 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $8,862,372 | 1,311,002 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,808,165 | 1,158,385 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $11,143,227 | 1,132,442 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,165,658 | 825,350 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,414,920 | 787,220 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,768,769 | 960,961 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $26,087,408 | 1,088,790 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $34,629,348 | 1,347,970 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $31,148,877 | 1,640,278 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $21,926,906 | 1,741,613 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $21,342,656 | 1,763,856 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $13,699,550 | 1,790,791 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||